Frontlight ResearchEarly access
TerminatedNo phase
Identification of Human Biomarkers Predictive of Diabetes Remission in Type 2 Diabetes Patient (BARIAKINES)
Key facts
- Who runs it
- University Hospital, Toulouse
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 23 people enrolled
- Started
- 27 Feb 2023
- Ended
- 27 Aug 2025
- Type of study
- Interventional
- Treatments tested
- blood samples
- collection of body tissues
- routine care procedure
- Record updated
- 12 May 2026
- Why it stopped
- Inclusion difficulties
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Obese patients of at least grade 2 (body mass index ≥ 35 kg/m²)
- Type 2 diabetics
- About to undergo bariatric surgery at the Toulouse University Hospital
- Affiliated or beneficiaries of a social security plan
- Having provided a free, informed and written consent, signed
Who cannot take part
- Type 1 diabetic subjects or Maturity-Onset Diabetes of the Youth
- Pregnant and breastfeeding women
- Vulnerable persons as defined in the Public Health Code: protected adults (guardianship, curators), unable to express their consent
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study focuses on identifying potentially predictive human circulating adipocyte and muscle biomarkers of diabetes remission after bariatric surgery in obese type 2 diabetic (T2D) subjects.
The group in the trial
- study armTreatment being tested
This arm consists of obese patients with type 2 diabetes who are scheduled for bariatric surgery.
Treatment: blood samples, collection of body tissues, and routine care procedure
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Identification of Human Circulating Adipocyte and Muscle Biomarkers Potentially Predictive of Diabetes Remission After Bariatric Surgery in Obese and Type 2 Diabetic Subjects.
- Record updated
- 12 May 2026